MINNEAPOLIS, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical
technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients
with obstructive sleep apnea, announced today that its management team will be presenting at the 8th Annual SVB Leerink Global
Healthcare Conference on February 28, 2019 at the Lotte New York Palace in New York.
Inspire is scheduled to present at 1:30 p.m. Eastern Time. The presentation will be accessible via a live webcast at: http://wsw.com/webcast/leerink32/insp/.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of
Inspire’s Investor website at www.investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally
invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only
FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep
apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989
